GLD has retreated from its $400 breakout, closing at $398.55 on Tuesday — a 1.7% pullback on the day and 0.6% down on the week — but the options market has not flinched, and that divergence is the week's most interesting tension.
The options signal remains the standout, and it continues to lean bullish despite the price dip. The put/call ratio fell further to 0.44, nearly two standard deviations below its 20-day average of 0.48. That is the lowest PCR reading in the past year — well beneath the 52-week floor of 0.39 — and marks a full reversal from the more cautious posture of early July, when the ratio was running near 0.62. Investors are not using the pullback to add downside protection. They are still buying calls. The drift lower in the PCR through the month, even as the price gave back ground, suggests the options market treats this as noise against the underlying bullish trend, not a structural turn.
The borrow market has loosened further since last week's note, reinforcing that there is no meaningful short-side pressure building. Availability has expanded to 330% — meaning roughly three shares are available to lend for every one currently borrowed. That compares with the tight 89–100% availability window seen in mid-July, when the borrow pool was nearly exhausted. Cost to borrow has fallen to 0.48%, roughly half the 0.86% level of late July and among the lowest readings of the past 30 days. Estimated short interest nudged up 14.7% over the past week to around 11 million shares, but with availability this loose and borrow costs this low, the week-on-week move reads as modest tactical repositioning rather than a conviction short. The ORTEX short score sits at 47, close to neutral and broadly flat over the past two weeks — consistent with a fund where short pressure is present but unremarkable.
The institutional picture is worth noting. BlackRock added 1.53 million shares as of July 31, the largest reported move among top holders, lifting its position to 3 million shares. Citigroup also added 464,000 shares through June 30. JPMorgan trimmed by 475,000 over the same period. The net read across the top-15 holders is modest accumulation, with no single name moving in a way that resets the narrative. Analyst data for GLD is not meaningful — the fund carries no current consensus coverage in the traditional sense, and the historical price-target data on file is more than six years stale.
The earnings-event history for GLD is technically populated — it tracks quarterly gold-price disclosures — and the pattern over the last four releases is consistent: the fund moved higher in the days that followed three of the past four events, with the August 4 release producing a 4.8% one-day gain and a nearly 8% five-day move. That five-day gain ended last week, and the current pullback has given back a portion of it.
What to watch next: whether the PCR holds near these call-heavy lows as the fund consolidates below $400, and whether the loosening availability trend continues or reverses if the gold price finds renewed upward momentum.
See the live data behind this article on ORTEX.
Open GLD on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
